|
61 |
Intracranial Metastatic Esthesioneuroblastoma Responsive to Temozolomide
Enthalten in Journal of neuro-oncology Bd. 70, Nr. 1, date:10.2004: 73-75
|
|
|
|
62 |
Neoadjuvant Gemcitabine/treosulfan Chemotherapy for Newly Diagnosed Glioblastoma
Enthalten in Journal of neuro-oncology Bd. 59, Nr. 2, date:9.2002: 151-155
|
|
|
|
63 |
Glioma Cell Invasion: Regulation of Metalloproteinase Activity by TGF-β
Enthalten in Journal of neuro-oncology Bd. 53, Nr. 2, date:6.2001: 177-185
|
|
|
|
64 |
Treosulfan Chemotherapy for Recurrent Malignant Glioma
Enthalten in Journal of neuro-oncology Bd. 49, Nr. 3, date:9.2000: 231-234
|
|
|
|
65 |
1H-NMR-based metabolic profiling identifies non-invasive diagnostic and predictive urinary fingerprints in 5q spinal muscular atrophy
Enthalten in Orphanet journal of rare diseases Bd. 16, 20.10.2021, Nr. 1, date:12.2021: 1-16
|
|
|
|
66 |
A H3K27M-targeted vaccine in adults with diffuse midline glioma
Enthalten in Nature medicine Bd. 29, 21.9.2023, Nr. 10, date:10.2023: 2586-2592
|
|
|
|
67 |
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
Enthalten in Journal of neuro-oncology Bd. 146, 27.11.2019, Nr. 1, date:1.2020: 79-89
|
|
|
|
68 |
Actively personalized vaccination trial for newly diagnosed glioblastoma
Enthalten in Nature Bd. 565, 19.12.2018, Nr. 7738, date:1.2019: 240-245
|
|
|
|
69 |
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities
Enthalten in Acta neuropathologica Bd. 130, 19.6.2015, Nr. 3, date:9.2015: 407-417
|
|
|
|
70 |
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas
Enthalten in Neurological research and practice Bd. 4, 23.5.2022, Nr. 1, date:12.2022: 1-7
|
|
Administration
